• OPEN AN ACCOUNT
Indian Indices
Nifty
25,111.45 -100.60
(-0.40%)
Sensex
82,259.24 -375.24
( -0.45%)
Bank Nifty
56,828.80 -340.15
( -0.59%)
Nifty IT
37,138.55 -522.15
( -1.39%)
Global Indices
Nasdaq
44,515.72 239.93
(0.54%)
Dow Jones
6,318.70 34.00
(0.54%)
Hang Seng
39,856.94 193.54
(0.49%)
Nikkei 225
8,972.64 46.09
(0.52%)
Forex
USD-INR
85.90 0.01
(0.01%)
EUR-INR
100.04 -0.25
(-0.25%)
GBP-INR
115.25 -0.37
(-0.32%)
JPY-INR
0.58 0.00
(-0.51%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
160.63
35.85
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

bcl industries ltd
Adcon Capital Services standalone net profit rises 86.96% in the March 2025 quarter
May 31,2025
Net profit of Adcon Capital Services rose 86.96% to Rs 0.43 crore in the quarter ended March 2025 as against Rs 0.23 crore during the previous quarter ended March 2024. Sales rose 147.22% to Rs 0.89 crore in the quarter ended March 2025 as against Rs 0.36 crore during the previous quarter ended March 2024.

For the full year,net profit rose 336.00% to Rs 2.18 crore in the year ended March 2025 as against Rs 0.50 crore during the previous year ended March 2024. Sales rose 92.86% to Rs 3.24 crore in the year ended March 2025 as against Rs 1.68 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.890.36 147 3.241.68 93
OPM %68.5438.89 -84.5730.36 -
PBDT0.610.14 336 2.740.51 437
PBT0.610.14 336 2.740.51 437
NP0.430.23 87 2.180.50 336